Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
D004351:Drug Resistance; D004961:Estramustine / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D004967:Estrogens; D009588:Nitrogen Mustard Compounds; D004961:Estramustine